Sin embargo, algunos pacientes presentan una HP “desproporcionada”, a pesar de tener una mínima afectación funcional y de seguir un tratamiento óptimo. DERRAME PLEURAL UV M.I.D sobre infectado. FIBRILACIÒN AURICULAR GASTRITIS DIABETES MELLITUS HTA CAUSAS CASO clínico. Anamnesis Remota A. Mórbidos: Cesárea Enfermedades Antecedentes Personales Nombre: T.C.H.. Sexo: Femenino Edad: 65 años.

Author: Vojin Dilrajas
Country: Trinidad & Tobago
Language: English (Spanish)
Genre: Health and Food
Published (Last): 9 November 2008
Pages: 359
PDF File Size: 10.78 Mb
ePub File Size: 20.36 Mb
ISBN: 656-4-58732-131-4
Downloads: 38628
Price: Free* [*Free Regsitration Required]
Uploader: Kelkree

Chronic obstructive pulmonary disease COPD is a chronic disease causing increasing healthcare costs worldwide.

Another respiratory disease causing high costs and morbidity is community-acquired pneumonia CAP. Because of the constant growth in the population with both diseases CAP and COPDanalyzing their clinical characteristics is important. Several cellular factors are known to contribute to differences in clinical expression: The use of new biomarkers procalcitonin, pro-adrenomedullin and copeptin help to distinguish among these clinical pictures. To decrease morbidity and mortality, clinical guidelines on antibiotic therapy must be followed and this therapy should be prescribed to patients with CAP and COPD.

There are also prevention measures such as the pneumococcal vaccine whose role in the prevention of pneumococcal CAP should be further sobreinfetado. The present review aims to elucidate some of the above-mentioned issues. Chronic obstructive pulmonary disease and pneumonia. The present review aims to elucidate some of the above-mentioned issues. Costs of chronic bronchitis and COPD: Chest, sobrsinfectado, pp. Sobreinfectafo among COPD patients using inhaled corticosteroids and long-acting bronchodilators.


Prim Care Respir J. Thorax, 64pp. Puig de la, A.

CASO CLINICO by liseth albarracin ramirez on Prezi

Bacterial colonization of distal airways in healthy subjects and chronic lung disease: Eur Respir J, 10pp. Variability and effects of bronchial colonisation in patients with moderate COPD. Eur Respir J, 35pp. A one-year prospective study epox infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia.

Respir Med,pp.

A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: Int J Antimicrob Agents, 33pp. Macrophage activation in exacerbated chronic obstructive pulmonary disease with and without community- acquired pneumonia.

EPOC e hipertensión pulmonar | Archivos de Bronconeumología

Eur Respir J,http: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med,pp. Community-acquired pneumonia in chronic obstructive pulmonary disease: COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur Respir J, 28pp. BMC Infect Dis, 9pp. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections.

Eur J Clin Invest, 37pp. Changes of plasma adrenomedullin level during the process from chronic bronchitis to chronic cor-pulmonale. C-reactive protein velocity following antibiotics in patients with chronic obstructive pulmonary disease exacerbation and community acquired pneumonia.

Eur J Intern Med, 20pp.

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. Pneumonia risk tratamjento COPD patients receiving inhaled corticosteroids alone or in combination: Eur Respir J, 34pp.

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: Arch Intern Med,pp. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: JAMA,pp. Budesonide and the risk of pneumonia: Lancet,pp. Drugs, 69pp. Clin Infect Dis, 44pp. Risk factors of treatment failure in community acquired pneumonia: Thorax, 59pp. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD.


Thorax, 61pp. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma.

J Gen Intern Med, 22pp. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD.


Pneumococcal vaccination for patients with COPD: Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J, 27pp. Respirology, 12pp. Fluticasone and budesonide inhibit cytokine release in human lung tratamiebto cells and alveolar macrophages. Allergy, 54pp. Respir Res, 7pp.

Si continua navegando, consideramos que acepta su uso. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.

Are you a health professional able to prescribe or dispense drugs?